Skip to main content
NVDA+0.10%AAPL-0.10%GOOGL+0.28%MSFT0.00%AMZN+0.25%TSM-0.26%SPCX+0.03%META-0.36%AVGO+0.15%TSLA-0.14%LLY+0.03%BRK-B0.00%MU+0.09%SKHY+0.02%WMT-0.01%JPM-0.02%AMD-0.06%V0.00%XOM0.00%JNJ+0.02%ASMLa-0.87%MA-0.02%ABBV+0.01%CVX+0.01%INTC-0.43%0700.HK+0.94%COST-0.01%1398.HK-1.50%CSCO-0.01%KO-0.01%ORCL-0.03%UNH-0.01%PG+0.05%BAC+0.01%1816.HK+0.44%3988.HK-0.50%HD-0.06%CAT-0.04%0005.HK-1.04%PM+0.03%HSBA.L-1.07%AP2d-0.03%0857.HK-0.93%0939.HK+0.51%AMAT0.00%GE-0.01%1288.HK-1.94%DELL+0.04%LRCX0.00%NVS-0.02%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPCHF0.00%CHFNOK0.00%GBPUSD0.00%EURPLN0.00%PLNJPY0.00%NZDMXN0.00%GBPCAD0.00%GBPNZD0.00%GBPSGD0.00%NZDCAD0.00%GBPZAR0.00%CADCHF0.00%EURDKK0.00%EURSEK0.00%EURCAD0.00%CHFJPY0.00%EURUSD0.00%EURJPY0.00%EURNZD0.00%GBPAUD0.00%EURNOK0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%AUDCHF0.00%USDSGD0.00%CADJPY0.00%NZDJPY0.00%USDHKD0.00%USDDKK0.00%USDZAR0.00%USDPLN0.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%W10.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD-0.28%ETHUSD+22.11%USDTUSD+0.03%XRPUSD+15.55%SOLUSD+15.78%TRXUSDT+0.67%ZECUSDT+0.91%DOGEUSD+20.76%XMRUSDT-3.13%LINKUSD+23.15%BCHUSDT+0.99%XLMUSD-1.43%UNIUSD+1.78%LTCUSD+17.32%SUIUSD-1.11%HBARUSDT-0.03%TONUSD+36.45%TAOUSDT+1.23%AAVEUSD-0.24%DOTUSDT-1.05%ICPUSDT-0.73%ONDOUSDT-0.32%WLDUSDT-2.67%ARBUSDT+0.17%JUPUSDT-1.25%ATOMUSDT+0.41%INJUSDT+4.72%STXUSDT+0.56%TIAUSDT+0.19%PYTHUSDT+5.34%FETUSDT-1.80%SEIUSDT-3.15%IMXUSDT-1.05%GRTUSDT-1.95%OPUSDT-1.73%IOTAUSDT-1.45%WIFUSDT-4.11%POLUSDT+0.16%AXSUSDT-1.60%EOSUSDT-2.90%FARTCOINUSDT-2.19%DYDXUSDT-2.61%GALAUSDT-2.36%ORDIUSDT-1.18%RONINUSDT-1.68%NOTUSDT0.00%NVDA+0.10%AAPL-0.10%GOOGL+0.28%MSFT0.00%AMZN+0.25%TSM-0.26%SPCX+0.03%META-0.36%AVGO+0.15%TSLA-0.14%LLY+0.03%BRK-B0.00%MU+0.09%SKHY+0.02%WMT-0.01%JPM-0.02%AMD-0.06%V0.00%XOM0.00%JNJ+0.02%ASMLa-0.87%MA-0.02%ABBV+0.01%CVX+0.01%INTC-0.43%0700.HK+0.94%COST-0.01%1398.HK-1.50%CSCO-0.01%KO-0.01%ORCL-0.03%UNH-0.01%PG+0.05%BAC+0.01%1816.HK+0.44%3988.HK-0.50%HD-0.06%CAT-0.04%0005.HK-1.04%PM+0.03%HSBA.L-1.07%AP2d-0.03%0857.HK-0.93%0939.HK+0.51%AMAT0.00%GE-0.01%1288.HK-1.94%DELL+0.04%LRCX0.00%NVS-0.02%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPCHF0.00%CHFNOK0.00%GBPUSD0.00%EURPLN0.00%PLNJPY0.00%NZDMXN0.00%GBPCAD0.00%GBPNZD0.00%GBPSGD0.00%NZDCAD0.00%GBPZAR0.00%CADCHF0.00%EURDKK0.00%EURSEK0.00%EURCAD0.00%CHFJPY0.00%EURUSD0.00%EURJPY0.00%EURNZD0.00%GBPAUD0.00%EURNOK0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%AUDCHF0.00%USDSGD0.00%CADJPY0.00%NZDJPY0.00%USDHKD0.00%USDDKK0.00%USDZAR0.00%USDPLN0.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%W10.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD-0.28%ETHUSD+22.11%USDTUSD+0.03%XRPUSD+15.55%SOLUSD+15.78%TRXUSDT+0.67%ZECUSDT+0.91%DOGEUSD+20.76%XMRUSDT-3.13%LINKUSD+23.15%BCHUSDT+0.99%XLMUSD-1.43%UNIUSD+1.78%LTCUSD+17.32%SUIUSD-1.11%HBARUSDT-0.03%TONUSD+36.45%TAOUSDT+1.23%AAVEUSD-0.24%DOTUSDT-1.05%ICPUSDT-0.73%ONDOUSDT-0.32%WLDUSDT-2.67%ARBUSDT+0.17%JUPUSDT-1.25%ATOMUSDT+0.41%INJUSDT+4.72%STXUSDT+0.56%TIAUSDT+0.19%PYTHUSDT+5.34%FETUSDT-1.80%SEIUSDT-3.15%IMXUSDT-1.05%GRTUSDT-1.95%OPUSDT-1.73%IOTAUSDT-1.45%WIFUSDT-4.11%POLUSDT+0.16%AXSUSDT-1.60%EOSUSDT-2.90%FARTCOINUSDT-2.19%DYDXUSDT-2.61%GALAUSDT-2.36%ORDIUSDT-1.18%RONINUSDT-1.68%NOTUSDT0.00%
DA

DaVita Inc. (DVA)

NYSE • Healthcare

$183.64
-$2.46 (-1.3%)
Market closed

October 23, 2026 at 20:00 UTC

Open$184.52
Day Range$183.46 - $187.52
Avg. Volume (3M)639.6K
Market Cap$11.7B
P/E Ratio15.8
52 Week Range
$101$247.49
Next EarningsIn 4 daysOct 29, 2026

Interactive Chart

20:00:39 UTC

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$3.5B100%
Gross Profitminus cost of goods$1.1B33%
Operating Incomeminus R&D and overhead$570.8M16%
Net Incomeminus taxes and the rest$265.3M7%

In plain terms: out of every $100 in revenue, DaVita Inc. keeps $7 as net profit.

Fundamentals & Financials

Revenue (TTM)
$14B
Net Income (TTM)
$847.4M
EPS (TTM)
$11.63
ROA (TTM)
4.79%
Current Ratio
1.47
Dividend Yield
1.04%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+4.9%Q1 2026$3.4
+19.1%Q2 2026$2.87
+3.6%Q3 2026$4.02
Next

Oct 29

in 4 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +3.6%

DaVita beat expectations on both the top and bottom line in the second fiscal quarter of 2026, reported Aug. 4, as revenue rose 5.2% to about $3.6 billion and adjusted EPS came in at $4.02. Revenue of about $3.6 billion topped the about $3.5 billion consensus by 1.7%, while EPS of $4.02 beat the $3.88 estimate by 3.6% and was up from $2.95 a year ago. Net income increased 33.1% to about $265 million from $199.3 million a year earlier, and operating income reached about $579 million. Operating cash flow was about $490 million, and DaVita returned capital with about $364 million of stock repurchases and about $150 million in dividends. For the next period, consensus calls for EPS of $3.92 on revenue of $3.53 billion.

Next report — what to expect

DaVita Inc. (DVA) reports next on November 4, 2026. Wall Street’s consensus calls for EPS of $3.55 on revenue of $3.52 billion. For trailing context, revenue grew +5.2% year over year last quarter. DaVita has beaten EPS in 6 of 8 most recent quarters.

View full earnings history

About DaVita Inc.

DaVita Inc. (NYSE: DVA) provides kidney dialysis treatments and broader renal care services in the healthcare sector, centered on outpatient, hospital, and home settings. The company generated $13.6 billion in FY2025 revenue. It serves patients with chronic kidney failure and related end-stage renal disease needs across the United States and ten countries outside the U.S.

Name
DaVita Inc.
CEO
Javier J. Rodriguez
Industry
Healthcare
Year Founded
1994
Employees
78,000

Today's Snapshot

AI-generated

The day ended with DVA 1.3% lower at 183.65, in line with a weaker sector. DVA reports earnings on 29 October.

Trading Volume

Below 10d avg (756.5K)

533.6K

vs S&P 500 Today

Underperforming Market

-0.80%

Updated: October 23, 2026 at 20:12 UTC

Technical Indicators

4 Buy2 Neutral2 Sell
DVA is rated a buy as recent price action sits above the short- and medium-term moving averages and above the 200-day level, indicating constructive longer-term breadth. Momentum and a slightly positive MACD support the advance while RSI and other oscillators are neutral, and ADX points to a lack of strong trend momentum. ATR reflects modest volatility near three percent of price and on-balance volume supports the move, offering confirmation. The pivot is close to the market and currently neutral. Technical takeaway: Buy — constructive moving-average alignment with modest momentum and confirming volume.
All signals
  • EMA (5 indicators)$167.81 - $185.85
    Buy
  • RSI (14)51.80
    Neutral
  • Stochastic %K (14, 3, 3)55.16
    Neutral
  • MACD Level (12, 26)0.05
    Buy

Peers & Related Assets

BAXBaxter International Inc.
$25.3-1.4%
FMSFresenius Medical Care AG & Co. KGaA
RMTIRockwell Medical, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.